[Silica-containing urinary stones--clinical issues to keep in mind]

Area of Science:

• Nephrology
• Urology
• Materials Science

Background:

• Urinary calculi formation is typically linked to supersaturation and crystallization of common substances like calcium oxalate and phosphates.
• Silicate uroliths, though rare, represent an under-recognized category of kidney stones.
• The occurrence of silicate stones without magnesium trisilicate abuse is exceptionally uncommon.

Observation:

• A 54-year-old male presented with a left ureterolith.
• X-ray diffraction analysis revealed the stone was composed of 40% silicate.
• The patient had a history of partial gastrectomy and long-term use of pentaerythrityltetranitrate (Pentalong).

Findings:

• Silicium dioxide was identified in the components of the patient's medication (Pentalong).
• This finding suggests a novel etiology for silicate urolithiasis, distinct from magnesium trisilicate antacid abuse.
• Silicate uroliths can be definitively identified using X-ray diffraction or infrared spectroscopy.

Implications:

• This case expands the known causes of silicate urolithiasis.
• Clinicians should consider medication components, particularly those containing silicates, in the differential diagnosis of rare stone types.
• Management strategies include increasing diuresis, altering medication, and reducing drug dosage to prevent calculus formation.